Bio-Rad Defends Labeling Under First Amendment, Prior FDA Inaction
This article was originally published in The Gray Sheet
Executive Summary
Disclaimers on unified labeling for lab "control products" that list unapproved tests are legal and do not promote off-label use, Bio-Rad maintains in a citizen petition recently filed with FDA
You may also be interested in...
CMS “Systems Approach” To Permit Equitable QC Testing Options Under CLIA
CLIA-regulated diagnostic manufacturers can change their package inserts and work with labs to take advantage of increased flexibility granted under CMS' new equitable quality control (EQC) testing options
IVD Symbol Draft Guidance Issued By FDA As EU Directive Looms
A response to Bio-Rad's citizen petition requesting that FDA allow use of symbols on in vitro diagnostic labeling in place of text is forthcoming
Bio-Rad Petition Seeks FDA Decision On IVD Labeling Symbol Use
The use of symbols on in vitro diagnostic labeling could be facilitated by inclusion of a legend box in the package insert, Bio-Rad Laboratories asserts in a citizen's petition requesting a change in FDA's IVD labeling policy.